Kai Dallmeier
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Hepatology top 1%
- Hepatitis Viruses Studies and Epidemiology
- Liver physiology and pathology
Papers in
-
- SARS-CoV-2 and COVID-19 Research 21
- Viral Infections and Outbreaks Research 3
- COVID-19 Clinical Research Studies 3
-
- Mosquito-borne diseases and control 32
- Co-authors
- Johan H. Neyts (53 shared papers)Yannick Debing (9 shared papers)Suzanne J. F. Kaptein (9 shared papers)Dirk Jochmans (4 shared papers)Xavier Nicolas de Lamballerie (3 shared papers)Pieter Leyssen (6 shared papers)Boris A. M. Pastorino (2 shared papers)Jan Paeshuyse (3 shared papers)
- Journals
- Antiviral Research (6 papers)Nature Communications (5 papers)Nature (4 papers)EBioMedicine (4 papers)Emerging Microbes & Infections (3 papers)
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Kai Dallmeier
85 papers receiving 4.9k citations
Kai Dallmeier's Hit Papers
Peers
Comparison fields: 5 of 119
- Infectious Diseases 1.9k
- Hepatology 753
- Public Health, Environmental and Occupational Health 986
- Immunology 341
- Virology 60
Countries citing papers authored by Kai Dallmeier
This map shows the geographic impact of Kai Dallmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Dallmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Dallmeier more than expected).
Fields of papers citing papers by Kai Dallmeier
This network shows the impact of papers produced by Kai Dallmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Dallmeier. The network helps show where Kai Dallmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Dallmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches Hit paper breakdown → | 2022 | 703 |
| 2 | 2020 | 654 | |
| 3 | Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug Hit paper breakdown → | 2012 | 330 |
| 4 | 2020 | 213 | |
| 5 | 2020 | 212 | |
| 6 | 2014 | 200 | |
| 7 | 2014 | 178 | |
| 8 | 2021 | 174 | |
| 9 | A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction Hit paper breakdown → | 2021 | 146 |
| 10 | 2020 | 142 | |
| 11 | 2013 | 127 | |
| 12 | 2012 | 122 | |
| 13 | 2016 | 113 | |
| 14 | 2021 | 111 | |
| 15 | 2011 | 98 | |
| 16 | Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates Hit paper breakdown → | 2023 | 96 |
| 17 | 2015 | 95 | |
| 18 | 2022 | 91 | |
| 19 | 2021 | 90 | |
| 20 | 2016 | 84 |
About Kai Dallmeier
Kai Dallmeier is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health, Hepatology, Immunology and Epidemiology, having authored 92 papers that have together received 5k indexed citations. Recurring topics across this work include Mosquito-borne diseases and control (32 papers), SARS-CoV-2 and COVID-19 Research (21 papers), Hepatitis Viruses Studies and Epidemiology (9 papers), Hepatitis B Virus Studies (8 papers), interferon and immune responses (4 papers), Hepatitis C virus research (3 papers), Viral Infections and Outbreaks Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (1.9k citations), Hepatology (753 citations), Public Health, Environmental and Occupational Health (986 citations), Immunology (341 citations) and Virology (60 citations). Kai Dallmeier has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Johan H. Neyts, Yannick Debing, Suzanne J. F. Kaptein, Dirk Jochmans, Xavier Nicolas de Lamballerie, Pieter Leyssen, Boris A. M. Pastorino, Jan Paeshuyse, Joanna Żmurko and Joana Rocha‐Pereira. Their work appears in journals such as Antiviral Research, Nature Communications, Nature, EBioMedicine and Emerging Microbes & Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.